Filing Details

Accession Number:
0000899243-21-000897
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-07 16:33:35
Reporting Period:
2021-01-05
Accepted Time:
2021-01-07 16:33:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1440132 S Joel Goldberg 940 Winter Street
Waltham MA 02451
Please See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-05 1,158 $46.26 73,293 No 4 M Direct
Common Stock Disposition 2021-01-05 39 $152.50 73,254 No 4 S Direct
Common Stock Disposition 2021-01-05 1,479 $152.51 71,775 No 4 S Direct
Common Stock Acquisiton 2021-01-06 25,149 $46.26 96,924 No 4 M Direct
Common Stock Disposition 2021-01-06 700 $153.06 96,224 No 4 S Direct
Common Stock Disposition 2021-01-06 900 $154.04 95,324 No 4 S Direct
Common Stock Disposition 2021-01-06 12,211 $155.20 83,113 No 4 S Direct
Common Stock Disposition 2021-01-06 9,938 $155.98 73,175 No 4 S Direct
Common Stock Disposition 2021-01-06 1,000 $157.00 72,175 No 4 S Direct
Common Stock Disposition 2021-01-06 400 $157.82 71,775 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2021-01-05 1,518 $0.00 1,518 $46.26
Common Stock NQ Stock Option (right to buy) Disposition 2021-01-06 25,149 $0.00 25,149 $46.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,149 2022-02-03 No 4 M Direct
0 2022-02-03 No 4 M Direct
Footnotes
  1. The Exercise Price included on the Form 4 filed on February 4, 2015 for the Reporting Person was incorrectly reported due to administrative error.
  2. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Goldberg on November 13, 2020.
  3. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $152.50 to $153.42. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  4. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $153.59 to $154.47. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $154.64 to $155.63. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  6. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $155.64 to $156.53. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  7. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $156.66 to $157.50. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  8. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $157.72 to $157.98. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  9. This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted.